Sunday, 20 May 2018 - 20:41
  • it
  • de
  • en
  • fr

Express Scripts

Express Scripts, gene therapies and affordability

An interesting article appeared on the website of Express Scripts, one of the major US-based health coverage organizations, addresses the issue of cost management for new gene therapies. Novartis’ Kymriah, recently approved by FDA, surely provides an efficacious treatment option…

Express Scripts to collaborate with Lilly to control insulins costs

Eli Lilly and Express Scripts are collaborating in order to offer interesting discounts on some diabetes treatments. The discounted prices will apply as of 1 January 2017 and will cover especially Humalog and Humulin, but also the Lantus follow-on biologic…

Express Scripts to cover Gilead’s Harvoni

Express Scripts announced that, as of next January, it will include Gilead’s Harvoni (ledipasvir/sofosbuvir) into its Hepatitis Cure Value Program. The drug will join the AbbVie’s hepatitis C treatment Viekira Pak. The decision was taken following successful talks about Harvoni’s…